45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
5,811
Insurances with rates
27
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 02792523 | INJECTION, OCRELIZUMAB, 1 MG | $58,500 | $40,950 | — | — | 36 |
| 02792899 | INJECTION, PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, PER 10 MG | $47,118 | $32,982 | — | — | 36 |
| 02792632 | INJECTION, BRENTUXIMAB VEDOTIN, 1 MG | $43,920 | $30,744 | — | — | 36 |
| 02792911 | INJECTION, ATEZOLIZUMAB, 10 MG | $41,722 | $29,205 | — | — | 36 |
| 02792940 | INJECTION, CEMIPLIMAB-RWLC, 1 MG | $40,805 | $28,563 | — | — | 36 |
| 02726948 | INJECTION, ALTEPLASE RECOMBINANT, 1 MG | $31,681 | $22,177 | — | — | 36 |
| 02792900 | INJECTION, PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF, PER 10 MG | $31,410 | $21,987 | — | — | 36 |
| 00736590 | OPERATING ROOM SERVICES - GENERAL CLASSIFICATION | $29,871 | $20,910 | — | — | 29 |
| 02792817 | BELANTAMAB (BLENREP) INJ 100MG | $29,797 | $20,858 | — | — | 36 |
| 02792950 | INJECTION, LURBINECTEDIN, 0.1 MG | $29,700 | $20,790 | — | — | 36 |
| 02792921 | INJECTION, ATEZOLIZUMAB, 10 MG | $28,355 | $19,848 | — | — | 36 |
| 02791572 | INJECTION, TENECTEPLASE, 1 MG | $28,179 | $19,726 | — | — | 36 |
| 02792925 | INJECTION, TENECTEPLASE, 1 MG | $28,179 | $19,726 | — | — | 36 |
| 02792731 | INJECTION, RITUXIMAB 10 MG AND HYALURONIDASE | $27,058 | $18,941 | — | — | 36 |
| 02792619 | INJECTION, NIVOLUMAB, 1 MG | $26,418 | $18,492 | — | — | 36 |
| 02792486 | INJECTION, PERTUZUMAB, 1 MG | $24,554 | $17,188 | — | — | 36 |
| 02726462 | INJECTION, PEGFILGRASTIM, EXCLUDES BIOSIMILAR, 0.5 MG | $23,105 | $16,173 | — | — | 36 |
| 02792333 | INJECTION, PEGFILGRASTIM, EXCLUDES BIOSIMILAR, 0.5 MG | $23,105 | $16,173 | — | — | 36 |
| 02791498 | INJECTION, OCTREOTIDE, DEPOT FORM FOR INTRAMUSCULAR INJECTION, 1 MG | $22,000 | $15,400 | — | — | 36 |
| 02792488 | INJECTION, PEMBROLIZUMAB, 1 MG | $21,656 | $15,160 | — | — | 36 |
| 02792599 | INJECTION, ADO-TRASTUZUMAB EMTANSINE, 1 MG | $21,554 | $15,088 | — | — | 36 |
| 02792928 | INJECTION, BENRALIZUMAB, 1 MG | $21,049 | $14,735 | — | — | 36 |
| 02792036 | INJECTION, OFATUMUMAB, 10 MG | $20,474 | $14,332 | — | — | 36 |
| 02889302 | INJECTION, IMMUNE GLOBULIN (PRIVIGEN), INTRAVENOUS, NON-LYOPHILIZED (E.G., LIQUID), 500 MG | $20,016 | $14,011 | — | — | 36 |
| 02792481 | INJECTION, RAMUCIRUMAB, 5 MG | $19,975 | $13,982 | — | — | 36 |
| 02792937 | INJECTION, ZICONOTIDE, 1 MICROGRAM | $19,952 | $13,966 | — | — | 36 |
| 02792933 | INJECTION, ROMIPLOSTIM, 1 MICROGRAM | $19,822 | $13,875 | — | — | 36 |
| 00736587 | Complete laser vaporization of prostate including control of bleeding using an endoscope | $19,358 | $13,551 | — | — | 36 |
| 03020082 | COMPONENT FEMORAL 6/R 71421176 | $18,178 | $12,724 | — | — | 29 |
| 03020073 | STEM OFFSET 15MM | $18,039 | $12,628 | — | — | 29 |
| 02726450 | INJECTION, DIGOXIN IMMUNE FAB (OVINE), PER VIAL | $17,906 | $12,534 | — | — | 36 |
| 02791345 | INJECTION, PANITUMUMAB, 10 MG | $17,099 | $11,969 | — | — | 36 |
| 03020061 | STEM LONG +10 71291573 | $16,567 | $11,597 | — | — | 29 |
| 03020006 | JOINT DEVICE (IMPLANTABLE) | $15,660 | $10,962 | — | — | 36 |
| 03020015 | COMPONENT FEMORAL 5/L 71422205 | $15,660 | $10,962 | — | — | 29 |
| 02791417 | INJECTION, OCTREOTIDE, DEPOT FORM FOR INTRAMUSCULAR INJECTION, 1 MG | $15,353 | $10,747 | — | — | 36 |
| 02792830 | INJECTION, RITUXIMAB-ABBS, BIOSIMILAR, (TRUXIMA), 10 MG | $15,220 | $10,654 | — | — | 36 |
| 02792730 | INJECTION, DURVALUMAB, 10 MG | $15,158 | $10,610 | — | — | 36 |
| 03020059 | STEM FEMORAL 7862-15 | $15,058 | $10,540 | — | — | 29 |
| 03020123 | STEM FEMORAL 7862-14 | $15,058 | $10,540 | — | — | 1 |
| 03020114 | STEM EXTENDED 7711-12-20 | $14,829 | $10,380 | — | — | 29 |
| 03020011 | COMPONENT FEMORAL 2/R 5414-015-02 | $14,824 | $10,377 | — | — | 29 |
| 03020091 | COMPONENT FEMORAL G/LT 5950-17-01 | $14,232 | $9,962 | — | — | 29 |
| 02724201 | INJECTION, CARMUSTINE, 100 MG | $14,151 | $9,906 | — | — | 36 |
| 02792867 | INJECTION, TRASTUZUMAB-PKRB, BIOSIMILAR, (HERZUMA), 10 MG | $14,137 | $9,896 | — | — | 36 |
| 02792919 | INJECTION, PEGFILGRASTIM-APGF (NYVEPRIA), BIOSIMILAR, 0.5 MG | $14,130 | $9,891 | — | — | 36 |
| 03020003 | COMPONENT FEMORAL 6/L 74021126 | $14,060 | $9,842 | — | — | 29 |
| 03020075 | COMPONENT FEMORAL 74021114 | $14,060 | $9,842 | — | — | 29 |
| 02791711 | INJECTION, DARBEPOETIN ALFA, 1 MICROGRAM (NON-ESRD USE) | $13,932 | $9,752 | — | — | 36 |
| 02792935 | INJECTION, TRASTUZUMAB-ANNS, BIOSIMILAR, (KANJINTI), 10 MG | $13,709 | $9,597 | — | — | 36 |
Showing top 50 of 5,811 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.